GIMV (EBR:GIMB) Gimv exits Biolam to its management backed by investors after a fast and successful growth trajectory into a leading French group of clinical testing labs
Directive transparence : information réglementée
09/12/2022 07:30
08/12/2023 12:00
08/12/2023 12:00
08/12/2023 12:00
08/12/2023 12:00
30/11/2023 21:24
30/11/2023 21:24
30/11/2023 21:24
30/11/2023 21:24
23/11/2023 06:58
23/11/2023 06:58